Peng-Ju Ye

Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma

Qian Ning, Yufeng Liu, Peng-Ju Ye et al. · ACS Applied Materials & Interfaces · 2019 · 62 citations

Pharmacy, Oncology, Pharmacology +17

Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo

Yueqing Wang, Cong Huang, Peng-Ju Ye et al. · Journal of Controlled Release · 2022 · 30 citations

Pharmacy, Oncology, Pharmaceutics +14

<i>In vitro</i> and <i>in vivo</i> evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy

Can Huang, Na‐Mei Li, Pei Gao et al. · Drug Delivery · 2017 · 29 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy

Peng-Ju Ye, Can Huang, Sa Yang et al. · Artificial Cells Nanomedicine and Biotechnology · 2018 · 20 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Fabrication and characterization of a novel self-assembling micelle based on chitosan cross-linked pectin–doxorubicin conjugates macromolecular pro-drug for targeted cancer therapy

Zhiping Li, Ming-Chao Jiang, Bo Chen et al. · RSC Advances · 2018 · 17 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17